A Phase 2 Study of Chronocort, a Modified-Release Formulation of Hydrocortisone, in the Treatment of Adults With Classic Congenital Adrenal Hyperplasia

CONTEXT: Treatment of congenital adrenal hyperplasia (CAH) is suboptimal. Inadequate suppression of androgens and glucocorticoid excess are common and current glucocorticoid formulations cannot replace the cortisol circadian rhythm. OBJECTIVES: The primary objective was to characterize the pharmacok...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Endocrinol Metab
Päätekijät: Mallappa, Ashwini, Sinaii, Ninet, Kumar, Parag, Whitaker, Martin J., Daley, Lori-Ann, Digweed, Dena, Eckland, David J. A., Van Ryzin, Carol, Nieman, Lynnette K., Arlt, Wiebke, Ross, Richard J., Merke, Deborah P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Endocrine Society 2015
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5393506/
https://ncbi.nlm.nih.gov/pubmed/25494662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-3809
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia